Fundación Gecp

This study tests whether giving chemotherapy plus immunotherapy before surgery works better than chemotherapy alone for people with advanced non-small cell lung cancer that can still be removed. About 90 patients will take part. The main goal is to see if the combined treatment l…

This study tests giving chemotherapy plus the immunotherapy drug nivolumab before surgery to people with a rare type of lung cancer called Pancoast tumor. The goal is to see if this combination can shrink the tumor enough to allow complete removal. After surgery, patients may rec…

This study tests a combination of two immunotherapy drugs (nivolumab and ipilimumab) plus two rounds of chemotherapy as a first treatment for people with advanced lung cancer that has spread to the brain. The goal is to see if this approach can control the cancer in the brain for…

This study is looking at 100 people with stage IIIA non-small cell lung cancer who are getting treatment before surgery. Researchers want to see if a blood test that looks for tumor DNA (ctDNA) can help predict how well the treatment is working and how long patients stay cancer-f…